Suprema Inc. (236200.KQ)
- Previous Close
35,700.00 - Open
0.00 - Bid --
- Ask --
- Day's Range
0.00 - 0.00 - 52 Week Range
0.00 - 36,000.00 - Volume
0 - Avg. Volume
59,013 - Market Cap (intraday)
245.042B - Beta (5Y Monthly) 0.24
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Aug 12, 2025 - Aug 18, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
34,000.00
Suprema Inc. develops and manufactures biometric and security products in South Korea and internationally. The company offers biometric access control systems, time and attendance solutions, fingerprint live scanners, mobile authentication solutions, and embedded fingerprint modules. It also provides access control, mobile access, and time and attendance solutions; BioSign, a mobile authentication solution; and integrated solutions, including BioStar 2, a Web-based security platform that enables to integrate with third-party systems. In addition, the company offers biometric readers, rf/ mobile readers, intelligent controller, open platform, peripherals, and OEM fingerprint modules. It serves construction, data center, healthcare, commercial, infrastructure, and manufacturing industries. Suprema Inc. was founded in 2000 and is headquartered in Seongnam-si, South Korea.
www.supremainc.comRecent News: 236200.KQ
View MorePerformance Overview: 236200.KQ
Trailing total returns as of 5/15/2025, which may include dividends or other distributions. Benchmark is KOSPI Composite Index (^KS11) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 236200.KQ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 236200.KQ
View MoreValuation Measures
Market Cap
246.42B
Enterprise Value
179.74B
Trailing P/E
7.58
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.28
Price/Book (mrq)
1.04
Enterprise Value/Revenue
1.66
Enterprise Value/EBITDA
4.31
Financial Highlights
Profitability and Income Statement
Profit Margin
30.02%
Return on Assets (ttm)
6.08%
Return on Equity (ttm)
14.74%
Revenue (ttm)
108.23B
Net Income Avi to Common (ttm)
32.49B
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
68.25B
Total Debt/Equity (mrq)
0.66%
Levered Free Cash Flow (ttm)
16.99B